Our results provide evidence that patients with increased CD4+FOXP3+ T cells and CD8+ T cells will not only have a favorable prognosis but may also be candidates for ICB as a result of high IFN‐γ and PDL1 expression in the tumor. The gene discussed is CD8A; the disease is neoplasm.